Stakeholder perspectives on scaling up medical device reprocessing: A qualitative study.

Rachel Hennein1,2, Emily Goddard3, Jodi D Sherman4,5

  • 1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, United States of America.

Plos One
|December 30, 2022
PubMed
Summary

Medical device reprocessing (MDR) offers environmental and cost benefits but faces barriers. Addressing regulatory, manufacturer, and hospital-level challenges can scale up this sustainability solution.